Radiation-induced plexopathy and fibrosis. Is magnetic resonance imaging the adequate diagnostic tool?

Ulrike Hoeller1, Michael Bonacker, Amira Bajrovic

  • 1Department of Radiotherapy and Radiooncology, Center of Radiology, University Hospital Eppendorf, Hamburg, Germany. ulrike.hoeller@vivantes.de

Abstract

Insights

Magnetic resonance imaging (MRI) did not reveal reliable signs of radiation-induced plexopathy (RIP). However, MRI accurately showed the severity of associated radiation-induced fibrosis, aiding in excluding tumor recurrence.

Area of Science:

  • Radiology
  • Oncology
  • Neurology

Background:

  • Radiation therapy for breast cancer and chest wall relapses can cause late sequelae.
  • Radiation-induced plexopathy (RIP) and fibrosis are common complications affecting the brachial plexus and surrounding tissues.

Purpose of the Study:

  • To investigate magnetic resonance imaging (MRI) features differentiating radiation-induced plexopathy (RIP) from radiation-induced fibrosis.
  • To assess the utility of MRI in diagnosing RIP and fibrosis after radiotherapy.

Main Methods:

  • Seven patients with late radiation sequelae underwent 1.5-T MRI, including T1, T2, STIR, and post-contrast sequences.
  • Clinical assessment (RTOG classification) of RIP and fibrosis severity was performed.
  • MRI findings were correlated with clinical scores.

Main Results:

  • No definitive MRI signs of RIP were identified in the brachial plexus.
  • Subtle changes in adjoining tissues were observed in patients with RIP.
  • MRI alterations in soft tissues correlated strongly with the clinical severity of fibrosis.

Conclusions:

  • Reliable MRI features for diagnosing RIP are lacking.
  • MRI is effective in assessing the severity of radiation-induced fibrosis.
  • The primary role of MRI in this context is to exclude tumor relapse.